UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Lbp Am Sa

Lbp Am Sa grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 11.1% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 35,609 shares of the healthcare conglomerate's stock after buying an additional 3,571 shares during the period. Lbp Am Sa's holdings in UnitedHealth Group were worth $18,650,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in UNH. Twelve Points Wealth Management LLC boosted its position in shares of UnitedHealth Group by 18.3% in the first quarter. Twelve Points Wealth Management LLC now owns 1,958 shares of the healthcare conglomerate's stock worth $1,026,000 after buying an additional 303 shares during the period. Court Place Advisors LLC boosted its position in UnitedHealth Group by 4.8% in the 1st quarter. Court Place Advisors LLC now owns 4,882 shares of the healthcare conglomerate's stock valued at $2,557,000 after buying an additional 223 shares during the last quarter. Cornerstone Planning Group LLC boosted its holdings in UnitedHealth Group by 68.6% in the first quarter. Cornerstone Planning Group LLC now owns 499 shares of the healthcare conglomerate's stock valued at $261,000 after purchasing an additional 203 shares during the last quarter. Dogwood Wealth Management LLC boosted its stake in shares of UnitedHealth Group by 13.1% during the 1st quarter. Dogwood Wealth Management LLC now owns 1,374 shares of the healthcare conglomerate's stock valued at $720,000 after buying an additional 159 shares during the last quarter. Finally, Linden Thomas Advisory Services LLC boosted its stake in UnitedHealth Group by 5.5% during the 1st quarter. Linden Thomas Advisory Services LLC now owns 4,534 shares of the healthcare conglomerate's stock valued at $2,375,000 after acquiring an additional 237 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

Analyst Ratings Changes

A number of research analysts have recently issued reports on the stock. TD Cowen downgraded shares of UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price target on the stock. in a research report on Monday, May 19th. Baird R W downgraded UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, June 11th. Piper Sandler cut their price objective on shares of UnitedHealth Group from $552.00 to $353.00 and set an "overweight" rating on the stock in a research note on Tuesday, June 3rd. Royal Bank Of Canada dropped their price target on shares of UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating on the stock in a research report on Friday, May 16th. Finally, JPMorgan Chase & Co. boosted their price objective on UnitedHealth Group from $405.00 to $418.00 and gave the stock an "overweight" rating in a research note on Friday, June 20th. One analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have assigned a buy rating to the company's stock. According to MarketBeat, UnitedHealth Group presently has an average rating of "Moderate Buy" and an average target price of $415.57.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Kristen Gil bought 3,700 shares of the firm's stock in a transaction dated Thursday, May 15th. The stock was purchased at an average cost of $271.17 per share, with a total value of $1,003,329.00. Following the transaction, the director directly owned 3,818 shares in the company, valued at $1,035,327.06. This trade represents a 3,135.59% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Patrick Hugh Conway sold 589 shares of UnitedHealth Group stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the sale, the chief executive officer directly owned 10,398 shares of the company's stock, valued at approximately $3,171,390. This trade represents a 5.36% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders bought 109,408 shares of company stock valued at $31,607,768. Corporate insiders own 0.28% of the company's stock.

UnitedHealth Group Trading Up 1.2%

UNH opened at $307.50 on Wednesday. The firm has a market cap of $278.95 billion, a PE ratio of 12.88, a price-to-earnings-growth ratio of 1.45 and a beta of 0.45. UnitedHealth Group Incorporated has a twelve month low of $248.88 and a twelve month high of $630.73. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85. The firm's fifty day moving average is $320.63 and its two-hundred day moving average is $444.69.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same period in the prior year, the business earned $6.91 EPS. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were given a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.87%. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date of this dividend was Monday, June 16th. UnitedHealth Group's dividend payout ratio is presently 37.02%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.